4/21/2011

The FDA tentatively approved Lupin's extended-release metformin hydrochloride, a generic version of
Watson Pharmaceuticals' diabetes treatment Fortamet. The drug, available in 500 milligrams and 1,000 milligrams, is given as adjunct therapy to diet and exercise in adults with type 2 diabetes.

Related Summaries